The key risks discussed in Evolent Health EVH earnings Q1 2026 EPS Beats Forecasts CTKB Cytek reports widerthanexpected Q4 2025 pershare loss and tepid yearoveryear revenue growth shares dip modestly The investment case for Standard SMP in simple terms Slight Dip 20260511 Service SCI Macro Impact Service posts 89 EPS miss with no revenue estimates